Loading cancer entity…
Loading cancer entity…
Clinical trials
3,221 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (571)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00025181 | Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery | completed | Phase 1 | 19 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00028431 | Novel Adjuvants for Peptide-Based Melanoma Vaccines | completed | Phase 1 | 19 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00031733 | Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma | completed | Phase 2 | 60 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00085189 | Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma | completed | Phase 2 | 42 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00334776 | Vaccine Therapy in Treating Patients With Metastatic Melanoma | completed | Phase 2 | 6 | University of Southern CaliforniaOTHER | 1 | May 21, 2014 | clinicaltrials |
| NCT00669019 | Saracatinib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery | completed | Phase 2 | 23 | National Cancer Institute (NCI)NIH | 1 | May 21, 2014 | clinicaltrials |
| NCT00281957 | Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery | completed | Phase 2 | 109 | National Cancer Institute (NCI)NIH | 1 | May 20, 2014 | clinicaltrials |
| NCT00816374 | Tailored Intervention for Melanoma Patient's Families | completed | N/A | 553 | Fox Chase Cancer CenterOTHER | 1 | May 16, 2014 | clinicaltrials |
| NCT00436605 | Dasatinib in Treating Patients With Stage III Melanoma That Cannot Be Removed By Surgery or Stage IV Melanoma | completed | Phase 2 | 39 | National Cancer Institute (NCI)NIH | 1 | May 15, 2014 | clinicaltrials |
| NCT00651157 | Viral Therapy in Treating Patients With Metastatic Melanoma | completed | Phase 2 | 23 | National Cancer Institute (NCI)NIH | 1 | Apr 22, 2014 | clinicaltrials |
| NCT01339663 | Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic Melanoma | completed | Phase 1 | 12 | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 21, 2014 | clinicaltrials |
| NCT00349206 | Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma | completed | Phase 1 | 69 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2014 | clinicaltrials |
| NCT01014351 | Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma | completed | Phase 2 | 70 | SCRI Development Innovations, LLCOTHER | 1 | Mar 26, 2014 | clinicaltrials |
| NCT00356460 | Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma | completed | Phase 1 | 29 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Mar 19, 2014 | clinicaltrials |
| NCT00004135 | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer | completed | Phase 2 | 19 | University of ChicagoOTHER | 1 | Mar 7, 2014 | clinicaltrials |
| NCT00184275 | Characterization of Brain Metastases | completed | — | 26 | Norwegian University of Science and TechnologyOTHER | 1 | Mar 7, 2014 | clinicaltrials |
| NCT00084214 | STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma | completed | Phase 1 / Phase 2 | 103 | Synta Pharmaceuticals Corp.INDUSTRY | 1 | Mar 6, 2014 | clinicaltrials |
| NCT02074605 | Cognitive Effects of Interferon in Patients With Melanoma | completed | — | 36 | University of ArizonaOTHER | 1 | Feb 28, 2014 | clinicaltrials |
| NCT00631618 | Clinical Trial of Sutent to Treat Metastatic Melanoma | completed | Phase 2 | 12 | California Pacific Medical Center Research InstituteOTHER | 1 | Feb 25, 2014 | clinicaltrials |
| NCT00313508 | Dendritic Cell Vaccination During Lymphoid Reconstruction | completed | Phase 1 | 18 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Feb 21, 2014 | clinicaltrials |
| NCT00012064 | Vaccine Therapy in Treating Patients With Stage IV or Recurrent Melanoma | completed | Phase 1 / Phase 2 | 56 | Lisata Therapeutics, Inc.INDUSTRY | 1 | Jan 29, 2014 | clinicaltrials |
| NCT00672542 | Immunotherapy of Melanoma With Tumor Antigen RNA and Small Inhibitory RNA Transfected Autologous Dendritic Cells | completed | Phase 1 | 12 | Scott PruittOTHER | 1 | Jan 23, 2014 | clinicaltrials |
| NCT00004196 | Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis | completed | Phase 3 | 3,000 | University of Alabama at BirminghamOTHER | 1 | Jan 20, 2014 | clinicaltrials |
| NCT00436930 | Vaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic Melanoma | completed | Phase 2 | 200 | Hoag Memorial Hospital PresbyterianOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00462423 | Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II Study(AbraxAvast) | completed | Phase 2 | 50 | Lynn E. Spitler, MDOTHER | 1 | Jan 8, 2014 | clinicaltrials |
| NCT00016263 | Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant Melanoma | completed | Phase 3 | — | Genta IncorporatedINDUSTRY | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00796991 | Drug-Drug Interaction - 3 Arm - Carboplatin/Paclitaxel, Dacarbazine | completed | Phase 1 | 72 | Bristol-Myers SquibbINDUSTRY | 1 | Jan 6, 2014 | clinicaltrials |
| NCT01077050 | SciBase International Melanoma Pivotal Study | completed | N/A | 1,951 | SciBase ABOTHER | 2 | Dec 30, 2013 | clinicaltrials |
| NCT00002892 | Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma | completed | Phase 3 | 1,000 | Institute of Cancer Research, United KingdomOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00081042 | ABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic Melanoma | completed | Phase 2 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00597038 | A Phase I/II Study of Dasatinib and Dacarbazine | completed | Phase 1 / Phase 2 | 50 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 16, 2013 | clinicaltrials |
| NCT00598507 | Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic Melanoma | completed | Phase 2 | 35 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 11, 2013 | clinicaltrials |
| NCT00005875 | Nitrocamptothecin in Treating Patients With Metastatic Melanoma | completed | Phase 2 | — | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00007969 | Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma | completed | Phase 1 / Phase 2 | — | QLT Inc.INDUSTRY | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00107159 | Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma | completed | Phase 2 | 37 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00255762 | Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery | completed | Phase 2 | 47 | National Cancer Institute (NCI)NIH | 1 | Oct 28, 2013 | clinicaltrials |
| NCT00526149 | BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors | completed | Phase 2 | 76 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Oct 7, 2013 | clinicaltrials |
| NCT00395070 | A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma | completed | Phase 3 | 390 | VicalINDUSTRY | 14 | Sep 13, 2013 | clinicaltrials |
| NCT00498836 | Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma | completed | Phase 2 | 18 | Clavis PharmaINDUSTRY | 3 | Sep 12, 2013 | clinicaltrials |
| NCT00002952 | Vaccine Therapy and Interleukin-12 in Treating Patients With Metastatic Melanoma | completed | Phase 1 / Phase 2 | 20 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00004141 | Combination Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic Melanoma | completed | Phase 2 | 46 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00004153 | Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma | completed | N/A | 106 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00203879 | Study of MAGE-3/Melan-A/gp 100/NA17 and rhIL-12 With/Out Low Dose IL-2 in Metastatic Melanoma | completed | Phase 2 | 19 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT01743157 | Biochemotherapy and Bevacizumab Followed by Consolidation Therapy With Ipilimumab for Metastatic Melanoma(BBI) | completed | Phase 1 / Phase 2 | 24 | California Pacific Medical Center Research InstituteOTHER | 1 | Aug 29, 2013 | clinicaltrials |
| NCT00014456 | Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 35 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 28, 2013 | clinicaltrials |
| NCT00246012 | A Safety and Efficacy Study of Intetumumab, Alone and in Combination With Dacarbazine, in Participants With Stage 4 Melanoma | completed | Phase 1 / Phase 2 | 144 | Centocor, Inc.INDUSTRY | 3 | Aug 19, 2013 | clinicaltrials |
| NCT00563823 | Vatalanib in Treating Patients With Metastatic Cutaneous Melanoma That Cannot be Removed by Surgery | completed | Phase 2 | 34 | Cambridge University Hospitals NHS Foundation TrustOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00707174 | Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna | completed | N/A | 90 | University of UtahOTHER | 1 | Jul 31, 2013 | clinicaltrials |
| NCT00745862 | Illness Related Distress in Women With Clinically Localized Cutaneous Melanoma | completed | — | 118 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 25, 2013 | clinicaltrials |
Data updated 23 days agoSource updated May 22, 2014source: clinicaltrials